-
-
Summary Content
The STAR Trial (Tamoxifen and Raloxifene); FDA Actions
-
One in 5 Americans dies in or shortly after discharge from an intensive care unit (ICU), an outcome that exposes critical care clinicians to frequent discussions that concern end-of-life care.
-
Mueller and colleagues at the University Hospital in Basel, Switzerland, investigated the clinical utility and cost-effectiveness of immediately measuring the serum level of B-type natriuretic peptide (BNP) in patients presenting to the emergency department with acute dyspnea.
-
-
Artinian and colleagues performed a retrospective analysis on a large prospectively acquired database from ICUs across the United States to examine the effect of initiating early enteral feeding on outcomes in non-surgical, mechanically ventilated ICU patients.
-
All of the currently available non-invasive techniques for carotid artery imaging give accurate results when there is a high-grade stenosis (70-99%), but contrast-enhanced MRA is slightly more sensitive.
-
Pulmonary embolism occurs commonly in patients with unexplained exacerbations of chronic obstructive pulmonary disease.
-
That air travel is associated with increased risk of deep venous thrombosis (DVT) is well established; Obesity is a recognized risk factor for GERD; and Anti-TNF antibody (aTNFa) therapy offers significant benefit to sufferers of rheumatoid arthritis (RA).
-
The FDA has licensed a new vaccine to reduce the risk of shingles in the people 60 years of age and older.